A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin e 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer
A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin e 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer. Investigational New Drugs. 34:225-230.